Hovione, a Portugal-based international company with over 50 years' experience in the development and compliant manufacture of active pharmaceutical ingredients and drug product intermediates, plans to expand its production facility in East Windsor, New Jersey.
This investment is part of the company's strategy to increase its global development and commercial capacity to meet the increasing demands of Hovione's customers. The expansion will add an additional 30,600 square feet to its 24,000 square foot facility.
According to the firm, Hovione will introduce a new commercial spray dryer unit to complement their existing pilot unit and this installation will be specifically designed to handle potent drug substances. In addition the expansion will more than double the drug substance capacity at the site to support the needs of the current and future customer base. The expansion is expected to add approximately 60 new jobs to the current workforce.
"Expanding our manufacturing presence in USA highlights our commitment to our customers that want to manufacture their products in the US and to support the development needs of our ever expanding local customer base. The additional capacity will give us more flexibility and make us more agile to deal with our customer's fast paced projects." said Dr. Marco Gil, General Manager, Hovione New Jersey.
"This investment pays a tribute to the excellent work that Hovione New Jersey team has done to create a sustainable business for the company in the US. We trust the team in New Jersey to be an integral part of Hovione's overall expansion. " said Dave Hoffman, President of the US Operations. "The State and especially the local government have been extremely supportive of us in the past and in our growth plans for the future and we are excited to partner with them to create new jobs in the local community."
This expansion will give our customers more options for spray drying manufacturing at Hovione. With commercial scale facilities in Portugal, Ireland and the U.S. we offer unmatched supply risk management through our vast internal network of compliant manufacturing capacity.